loader

World Tenders & Procurement Opportunities

Search
Advanced Search

Pharmaceutical products - Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Tolvaptan (ATC-Code: C03XA01 und G04BX21)

World Biggest Tenders Source

This tender with title Pharmaceutical products - Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Tolvaptan (ATC-Code: C03XA01 und G04BX21) has been published on Bidding Source portal dated 12 Mar 2020 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

General Information

Germany

Pharmaceutical products - Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Tolvaptan (ATC-Code: C03XA01 und G04BX21)
Invitation for Bids
2020/S 050-118244
Germany
Germany-Hanover
12 Mar 2020
25 Feb 2022
English
Pharmaceutical products

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 SGB V for the active ingredients mentioned with the possibility of conclusion within the framework of the so-called open house procedure. - 759035 Germany Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 SGB V for the active ingredients mentioned with the possibility of conclusion within the framework of the so-called open house procedure. - 754261 Germany Pharmaceutical discount agreements from February 1, 2025 for various active ingredients within the framework of an open-house procedure - 760743 Germany Conclusion of non-exclusive discount agreements according to Section 130a Paragraph 8 SGB V (open house model) - 748842 Germany Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient minoxidil (C02DC01) within the framework of a so-called open-house model. - 761792 Germany Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient pegfilgrastim (L03AA13) within the framework of a so-called open-house model. - 759822 Germany Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient acetylsalicylic acid (B01AC06) within the framework of a so-called open-house model. - 759353 Germany Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient dornase alfa (R05CB13) within the framework of a so-called open-house model. - 759034 Germany Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient peginterferon beta-1a (L03AB13) within the framework of a so-called open-house model. - 758983 Germany Medicines containing the active ingredient budesonide (ATC: A07EA06) - 751732 Germany
Pharmaceutical products Tenders
Germany Tenders
Europe Tenders
Tenders
No. 12, 1 st floor, Block B2, EGS Business Park, World Trade Center, Bakirkoy - Istanbul - Turkey
info@biddingsource.com
24 X 7 online support
TOP
For viewing latest tenders published for your business in all over the World: Sign in Join free
For accessing full details of Tenders, Kindly choose the Plan that works for you: View Subscription Plans